Trademark Overview
On Tuesday, August 6, 2024, a trademark application was filed for SENTALSO with the United States Patent and Trademark Office. The USPTO has given the SENTALSO trademark a serial number of 98684995. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, August 6, 2024. This trademark is owned by Johnson & Johnson. The SENTALSO trademark is filed in the Pharmaceutical Products category with the following description:
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers